J.P. Morgan Maintains Neutral on C.R. Bard

J.P. Morgan is out with its report today on C.R. Bard BCR, maintaining Neutral. In a note to clients, J.P. Morgan writes, "We view Bard as an attractive mix of assets, with a sustainable longer term growth profile of 5-6% on the top line and 10-11% on the bottom line. From this base rate, we see upside potential for Bard from acquisitions or should healthcare volumes and/or device utilization levels improve in the quarters ahead." J.P. Morgan maintains a $104 PT on BCR. At the time of posting, shares of BCR were trading pre-market at $105.86, down 6.08% from Thursday's close.